SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-23-089461
Filing Date
2023-11-22
Accepted
2023-11-22 12:10:55
Documents
23

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea188720-424b4_elevailabs.htm 424B4 2425991
2 GRAPHIC image_001.jpg GRAPHIC 2710
3 GRAPHIC image_002.jpg GRAPHIC 4034
4 GRAPHIC image_003.jpg GRAPHIC 10682
5 GRAPHIC image_004.jpg GRAPHIC 10682
6 GRAPHIC image_005.jpg GRAPHIC 12432
7 GRAPHIC image_006.jpg GRAPHIC 8477
8 GRAPHIC image_007.jpg GRAPHIC 6978
9 GRAPHIC image_008.jpg GRAPHIC 14053
10 GRAPHIC image_009.jpg GRAPHIC 2313
11 GRAPHIC image_010.jpg GRAPHIC 8392
12 GRAPHIC image_011.jpg GRAPHIC 8909
13 GRAPHIC image_012.jpg GRAPHIC 9252
14 GRAPHIC image_013.jpg GRAPHIC 3159
15 GRAPHIC image_014.jpg GRAPHIC 16500
16 GRAPHIC image_015.jpg GRAPHIC 38866
17 GRAPHIC image_016.jpg GRAPHIC 1305
18 GRAPHIC image_017.jpg GRAPHIC 1305
19 GRAPHIC image_018.jpg GRAPHIC 28533
20 GRAPHIC image_019.jpg GRAPHIC 5364
21 GRAPHIC image_020.jpg GRAPHIC 1696
22 GRAPHIC image_021.jpg GRAPHIC 5364
23 GRAPHIC image_022.jpg GRAPHIC 8180
  Complete submission text file 0001213900-23-089461.txt   2718185
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-274755 | Film No.: 231431898
SIC: 2834 Pharmaceutical Preparations